GEVISKON (Suspension)

Active material: Calcium carbonate, sodium alginate, Natriya carbonate
When ATH: A02AX
CCF: Antacids
ICD-10 codes (testimony): K30, R12
When CSF: 11.01.04
Manufacturer: RECKITT BENCKISER HEALTHCARE (UK) Limited (Great Britain)

Pharmaceutical form, composition and packaging

◊ Oral suspension (Mint) viscous, opaque, from almost white to cream-colored, with mint odor.

Excipients: karʙomer, metilparagidroksiʙenzoat, propilparagidroksibenzoat, sodium saccharin, peppermint oil, Sodium hydroxide, Purified water.

100 ml – vials of dark glass.
150 ml – vials of dark glass.
300 ml – vials of dark glass.

Pharmacological action

Antacids. After intake of the drug quickly interacts with acidic contents of the stomach. When alginate gel, preventing the occurrence of gastro-oesophageal reflux. When the regurgitation of gel are more likely, than the content of the stomach, enters the esophagus, where reduces irritation of mucous membrane.

Pharmacokinetics

The mechanism of action of the preparation Geviskon does not depend on the suction in the bloodstream.

Testimony

-symptomatic treatment of dyspepsia, associated with high acidity gastric juice and gastroezofagealnam reflux (heartburn, acid belching, feeling of heaviness in the stomach after eating, incl. Pregnancy).

Dosage regimen

The drug is prescribed inside adults and children over 12 years by 10-20 ml after meals and at bedtime. The maximum daily dose – 80 ml.

Babies 6-12 years appoint 5-10 ml after meals and at bedtime. The maximum daily dose – 40 ml.

To elderly patients dose modification is not required.

Side effect

Rarely: allergic reactions.

Contraindications

- Children up to age 6 years;

- Hypersensitivity to the drug.

Pregnancy and lactation

Application of Geviskona in pregnancy and lactation (breast-feeding).

Cautions

IN 10 ml of suspension contains 141 mg (6.2 mmol) sodium. This should be taken into account when the need to respect a diet with limited salt content (congestive heart failure, renal impairment).

If there is no improvement within 7 days need to consult a doctor.

Effects on ability to drive vehicles and management mechanisms

Effects on ability to drive vehicles and management mechanisms absent.

Overdose

Symptoms: abdominal distention.

Treatment: symptomatic therapy.

Drug Interactions

Patient interaction drug Geviskon not installed.

Conditions of supply of pharmacies

The drug is resolved to application as an agent Valium holidays.

Conditions and terms

The drug should be stored out of reach of children at temperature from 15 ° to 30 ° C. Shelf life – 3 year.